Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy Evercore ISI

Vertex Pharmaceuticals Inc.
Start price
€370.60
11.04.24 / 50%
Target price
€407.65
11.04.25
Performance (%)
16.50%
End price
€431.75
12.04.25
Summary
This prediction ended on 12.04.25 with a price of €431.75. The prediction had a final performance of 16.50%. Evercore_ISI has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Evercore_ISI has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vertex Pharmaceuticals Inc. 0.763% 0.763% -14.391%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by Evercore_ISI for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 16.50%
Target price 407.647
Change
Ends at 11.04.25

Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten

Evercore ISI 
0
Report Share
12.04.25
In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 16.50%
Target price 407.647
Change
Ends at 11.04.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $438.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat

Evercore ISI 
0
Report Share
11.04.24

Current prediction by Evercore_ISI for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€334.05
11.09.25
€406.03
11.09.26
14.37%
18:47

Evercore ISI 
11.09.25 50%